Breast cancer is a major and expanding health challenge, and neoadjuvant chemotherapy (NACT) is increasingly prescribed to facilitate breast surgery in advanced breast cancer with an ongoing demand for improved imaging methods accurately reflecting disease load. Tissue perfusion, a sensitive marker of cancer metabolism, can be derived from intravoxel incoherent motion (IVIM) model, and recent Bayesian algorithm yields improved sensitivity and precision in breast cancer by us and pancreatic cancer. We therefore hypothesise that IVIM model powered by Bayesian algorithm is able to detect early treatment-induced changes in tumour perfusion and diffusion, with the potential to impact patient care pathway.
This abstract and the presentation materials are available to members only; a login is required.